Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2 Billion | USD 9 Billion | 22% | 2021 |
FrequentlyAsked Questions
Rapidly increasing cancer cases across the world and the influx of chronic diseases in the geriatric population drive market growth for the gene panel market. There is a number of initiatives by different companies globally and the benefits of gene panels to fight cancer boost market growth as well.
According to the report by Zion Market Research, the global gene panel market was worth around $ 2 billion in 2021 and is predicted to grow around to $ 9 billion by 2028 at a CAGR rate of 22% over the forecast period
The market in North America accounts for the largest share due to the rising cases of chronic and infectious diseases here. There has been increasing support from the government for genomics research which increases the demand for gene panels here.
The key players in the global gene panel market are Agilent Technologies, Thermo Fisher Scientific, Hoffmann-La Roche Ltd, Qiagen, Illumina Inc., BGI Genomics, Integrated DNA Technologies, Inc., Genewiz, Novogene Corporation, Personalis, Inc., GATC Biotech AG, ArcherDX, Inc., GeneDX, Centogene Ag, and Invitae Corporation.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed